BamSEC and AlphaSense Join Forces
Learn More

Larimar Therapeutics Inc. – Transcripts

NASDAQ: LRMR    
Share price (9/22/26): $3.82    
Market cap (9/22/26): $397 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Other Revised 06/29/26 Larimar Therapeutics, Inc. - Special Call 06/29/26
Other Revised 01/14/26 Larimar Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:00 AM 01/14/26
CY 2025
Other Revised 09/29/25 Larimar Therapeutics, Inc. - Special Call 09/29/25
Other Revised 06/23/25 Larimar Therapeutics, Inc. - Special Call 06/23/25
CY 2024
Other Revised 12/16/24 Larimar Therapeutics, Inc. - Special Call 12/16/24
Other Revised 02/12/24 Larimar Therapeutics, Inc. - Special Call 02/12/24
CY 2023
Other Revised 07/25/23 Larimar Therapeutics, Inc. - Special Call 07/25/23
Earnings Revised 05/15/23 Larimar Therapeutics, Inc., Q1 2023 Earnings Call, May 15, 2023 05/15/23
CY 2022
Other Revised 09/14/22 Larimar Therapeutics, Inc. - Special Call 09/14/22
CY 2021
Other Revised 09/09/21 Larimar Therapeutics, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 05:00 PM 09/09/21
Other Revised 05/11/21 Larimar Therapeutics, Inc. - Special Call 05/11/21
CY 2019
Other Revised 12/18/19 Chondrial Therapeutics, Inc., Zafgen, Inc. - M&A Call 12/18/19
Earnings Revised 03/11/19 Zafgen, Inc., Q4 2018 Earnings Call, Mar 11, 2019 03/11/19
CY 2018
Earnings Revised 11/07/18 Zafgen, Inc., Q3 2018 Earnings Call, Nov 07, 2018 11/07/18
Earnings Revised 08/07/18 Zafgen, Inc., Q2 2018 Earnings Call, Aug 07, 2018 08/07/18
Other Revised 06/25/18 Zafgen, Inc. - Special Call 06/25/18
Other Revised 05/09/18 Zafgen, Inc. Presents at 43rd annual Deutsche Bank Healthcare Conference, May-09-2018 10:00 AM 05/09/18
Earnings Revised 05/08/18 Zafgen, Inc., Q1 2018 Earnings Call, May 08, 2018 05/08/18